TMS (Transcranial Magnetic Stimulation) SUSPENDED DUE TO COVID-19
Dr.
Friedman offers TMS, a non-invasive, non-systemic (not
circulating in the bloodstream) depression treatment.
TMS is the first depression treatment of its kind to
be approved by the U.S. Food and Drug Administration (October
2008). The treatment, which is far safer and more convenient
than electro-shock treatment (ECT), is clinically proven for the
treatment of major depression in adults who have failed to achieve satisfactory
improvement from antidepressant medication. This innovative
treatment consists of focused, gentle magnetic stimulation (using a small MRI
magnet) for thirty 40-minute sessions over 4-6 weeks, without
use of sedation. Once inside the brain, the magnetic pulses
induce a mild electrical current to flow, which cannot be felt
by the patient, but which causes the brain cells to become
active and are thought to lead to the release of neurotransmitters such as serotonin,
norepinephrine and dopamine. Patients sit comfortably, watching TV while
awake, in a recliner chair during each session. After
treatment, patients can drive and resume normal activity.
TMS may be appropriate for you if some of the following
are true:
-you get inadequate benefit
from your current medication treatment -you are taking too much
medication to treat your depression -side effects outweigh the
benefits -depression is affecting your
ability to make a living -depression still controls too
much of your life.
More information is available at www.neurostar.com Read
testimonials by patients treated with TMS at www.thedepressionhopecenter.com Patients may learn about reimbursement by insurance on the Neurostar TMS website.
MEDICARE COVERS TMS FOR TREATMENT OF DEPRESSION.
TMS SERVICES ARE CURRENTLY SUSPENDED DUE TO COVID-19 UNTIL FURTHER NOTICE.
